Top 5 Stock Picks of Farallon Capital

4. Savara, Inc. (NASDAQ:SVRA)

Farallon Capital Equity Stake: $34.85 Million
Number of Hedge Fund Holders: 10

Headquartered in Austin, Texas, Savara, Inc. (NASDAQ:SVRA) develops inhaled therapies for rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor for treating autoimmune pulmonary alveolar proteinosis.

Savara, Inc. (NASDAQ:SVRA) is already up by more than 100% for the year, affirming its status as one of Farallon’s top stock picks in the healthcare sector. The hedge fund owns stakes worth $34.85 million, accounting for 0.19% of the portfolio.

During the second quarter, ten hedge funds had positions in Savara, Inc. (NASDAQ:SVRA), according to Insider Monkey’s database. 

Follow Savara Inc (NYSE:SVRA)

[/company-follow-email]